Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening
July 30, 2015 at 08:07 AM EDT
In a report published Thursday, RBC Capital analyst Randall Stanicky downgraded the rating on Depomed Inc(NASDAQ: DEPO) from ...